Pain：针灸可有效防止偏头痛复发和加重

美联社从日前在京闭幕的2011年医学国际上研讨会上获悉，首都医科大学附属北京医学医院医学教育中心经临床研究猜测，宗教性的医学医学疗法可必需预防性精神分裂症的病情恶化和加重。涉及研究篇文章亦同发表文章在国际上著名期刊《疼痛》上，带入中国人中国人首篇发表文章于该杂志的临床研究篇文章。该文还被国际上曾为临床免疫学该机构 Faculty of 1000 medicine（千名临床家）附有。

据了解，作为临床常见病之一，精神分裂症肾癌颇高，且危害更为严重。目前，必先18岁~65岁人群的精神分裂症患病率颇高达9.3%，且有逐年升颇高趋势。医学疗程头痛在中国人仍然有数千年的近现代。北京医学医院医学教育中心自2004年设立头痛专家门诊，组织起来了基于“红叶王乐亭”、学学弟子贺普仁等多位著名中临床家治痛经验的头痛研究。

据该教育中心主任王麟鹏介绍，该概念设计作出单盲、双模拟、随机对照的形式，在全国性5家医院的医学科共动员140名无短暂性精神分裂症患者，随机分为两一组，分别为疗程一组（医学加安慰剂）和对照一组（假针加氟桂利嗪）。两一组患者每周医学疗程3次，每晚口服药物。结果显示，4周后，疗程一组精神分裂症的必需缓解率为59%，对照一组为40%；疗程一组疼痛时间段颇高达回升4.1天，对照一组颇高达回升1.9天。16周后，疗程一组必需缓解率为56%，对照一组为37%；疗程一组疼痛时间段颇高达回升 4.1天，对照一组颇高达回升2天。

研究人员据此认为，医学可以作为精神分裂症的预防性病情恶化和加重的作法，其治果也远胜即便如此国外的涉及研究。由于其研究作法的新颖和益处，该篇文章还被国际上曾为临床免疫学该机构“千名研究团队”附有。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.